@FierceBiotech: We're looking for 2014's Fiercest women in biotech. More | Follow @FierceBiotech
@JohnCFierce: Purdue earns a nod--and a quick slap--for abuse-resistant painkiller. News | Follow @JohnCFierce
@DamianFierce: $GILD's idelalisib will carry a boxed warning over serious liver toxicities. Here's the FDA's announcement. Release | Follow @DamianFierce
@EmilyMFierce: GlaxoSmithKline steps closer to making world's first malaria vaccine. More from The Telegraph | Follow @EmilyMFierce
> Merck ($MRK) announced that the first patient has been enrolled in a global Phase III clinical study of letermovir (MK-8228), an investigational antiviral agent. Release
> Shares of Celsion ($CLSN) were buoyed this morning after the biotech said that it had gathered positive interim data from its ongoing open-label Phase II study of ThermoDox in recurrent chest wall breast cancer. Release
Medical Device News
@FierceMedDev: Nanoparticles point to cancerous tumors in MRIs. Article | Follow @FierceMedDev
@StacyALawrence: ICYMI yesterday: Sofinnova closes $500M venture fund, keeps late-stage focus. Article | Follow @StacyALawrence
@VarunSaxena2: Frieden: "What works for Ebola is old fashioned public health." Says developing vaccine is difficult. | Follow @VarunSaxena2
@MichaelGFierce: Most absorbent material on Earth gives poorly soluble drugs a boost. FierceDrugDelivery story | Follow @MichaelGFierce
@EmilyWFierce: The top 5 vaccine makers brought in 86% of all vaccine sales in 2013. Find out who made the list here. Feature | Follow @EmilyWFierce
> Zimmer reports solid Q2 sales gains but lowers full-year estimates. News
> Nanoparticles point to cancerous tumors in MRIs. Story
> Augmenix aims for profitability with $10.8M Series D round as Varian acquisition option expires. More
Pharma News
@FiercePharma: Top-read in FP Weds: News flash for biopharma bosses: More than half your employees want to leave. Story | Follow @FiercePharma
@TracyStaton: CVS Caremark lays out case for new specialty-drug pricing approach in JAMA editorial. More | Follow @TracyStaton
@EricPFierce: 3-D manufacturing being used in medical devices. When will pharma benefit? FierceMedicalDevices feature | Follow @EricPFierce
@CarlyHFierce: GlaxoSmithKline's the No. 3 vaccines maker now, but its Novartis assets may change that picture. More | Follow @CarlyHFierce
> BMJ targets Pradaxa safety, scolding Boehringer, FDA and EMA alike. Story
> Eli Lilly's Q2 profit sags on patent expirations but beats (low) expectations. Article
> Can Gilead break into cancer? With Zydelig approval, it gets its chance. More
Vaccines News
> Aduro nabs FDA 'breakthrough' nod for pancreatic cancer vaccine combo. More
> SEC charges CytoGenix CEO, 'serial con artist' with fraud. News
> Sinovac nabs Chinese vaccine tenders for hep A, influenza. Item
> GSK submits world's first malaria vaccine for EMA approval. Story
> Fluviral, FluLaval Tetra production on hold at Glaxo's troubled Quebec plant. Article
Pharma Manufacturing News
> Out with the new and in with the old after GSK trips up at vaccine plant. Story
> AmerisourceBergen deal with Walgreen reaps rewards, and costs. More
> FDA warns hospitals that Texas compounder's products are unsafe. Article
> Indian API maker voluntarily halts shipments to the U.S. Story
> Feds extract guilty plea from Turkish man accused of smuggling counterfeit Avastin. Report